Empowered Funds, LLC Novo Cure LTD Transaction History

Empowered Funds, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$75.08 - $121.99 $956,594 - $1.55 Million	-12,741 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $376,042 - $629,758	3,237 Added 34.06%	12,741 $1.48 Million
Q2 2021 Aug 04, 2021	BUY	$130.4 - $225.58 $1.24 Million - $2.14 Million	9,504 New	9,504 $2.11 Million
Q2 2020 Jul 16, 2020	SELL	$57.2 - $74.41 $791,648 - $1.03 Million	-13,840 Closed	0 $0
Q1 2020 Jul 16, 2020	BUY	$57.05 - $95.75 $789,572 - $1.33 Million	13,840 New	13,840 $931,000
Q1 2020 Apr 16, 2020	SELL	$57.05 - $95.75 $789,572 - $1.33 Million	-13,840 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$68.3 - $93.8 $48,288 - $66,316	707 Added 5.38%	13,840 $1.17 Million
Q3 2019 Nov 01, 2019	SELL	$61.86 - $97.8 $482,693 - $763,133	-7,803 Reduced 37.27%	13,133 $982,000
Q2 2019 Jul 09, 2019	SELL	$42.22 - $63.23 $272,530 - $408,149	-6,455 Reduced 23.57%	20,936 $1.32 Million
Q1 2019 May 10, 2019	BUY	$31.96 - $56.12 $875,416 - $1.54 Million	27,391 New	27,391 $1.32 Million

266

78.3M

970K

118K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.